E

Evolent Health, Inc. EVH

$3.81 $0.071.74% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Evolent Health, Inc. is a U.S.-based healthcare services and technology company focused on helping health plans, providers, and government-sponsored healthcare programs manage value-based care. The company operates primarily in the healthcare technology, specialty care management, and population health industries, supporting organizations that assume financial risk for patient outcomes and healthcare costs. Evolent’s core business model centers on administrative and clinical solutions that help payers and providers improve care quality while reducing medical expenses.

The company’s primary revenue drivers include specialty care management services, administrative platform services, and clinical solutions delivered through its operating segments and subsidiaries. Evolent has developed capabilities in oncology management, cardiology, musculoskeletal care, and surgical management through acquisitions and internal platform development. Originally founded in 2011 by leaders associated with The Advisory Board Company and UPMC Health Plan, Evolent evolved from a population health management company into a broader specialty-care and payer-services organization through acquisitions, strategic partnerships, and expansion into managed care support services.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
571 389 6000
Address
1812 N. Moore Street
Suite 1705
Arlington, VA 22209
Country
Year Founded

Headlines